EFG
NWBO
Ethos Financial Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6K | Buy |
49,050
+25,350
| +107% | +$6.51K | ﹤0.01% | 465 |
|
|
2025
Q1 | $6.51K | Hold |
23,700
| – | – | ﹤0.01% | 440 |
|
|
2024
Q4 | $6.51K | Hold |
23,700
| – | – | ﹤0.01% | 382 |
|
|
2024
Q3 | $8K | Hold |
23,700
| – | – | ﹤0.01% | 295 |
|
|
2024
Q2 | $10K | Hold |
23,700
| – | – | ﹤0.01% | 282 |
|
|
2024
Q1 | $12K | Buy |
+23,700
| New | +$12K | ﹤0.01% | 279 |
|
|
2023
Q2 | – | Sell |
-22,200
| Closed | -$13.9K | – | 168 |
|
|
2023
Q1 | $13.9K | Buy |
+22,200
| New | +$13.9K | ﹤0.01% | 187 |
|